Full Paper
recrystallization from chloroform and hexane provided 4 as a red
powder in 8.6% yield (41 mg, 0.058 mmol). HR-MALDI-FT-ICR-MS:
m/z 701.1428 (calcd for C44H25N6Zn: 701.1427 [M++H]); 1H NMR
(CDCl3, 500 MHz, 298 K): d=8.53 (d, J=7.0 Hz, 4H), 8.03 (d, J=
8.0 Hz, 4H), 7.83 (dd, J1 =7.0, J2 =7.0 Hz, 4H), 7.51 (d, J=8.0 Hz,
4H), 7.22 (dd, J1 =8.0, J2 =8.0 Hz, 4H), 7.02 ppm (d, J=7.0 Hz, 4H);
UV/Vis (CHCl3): lmax [nm] (e [molÀ1 dm3 cmÀ1])=563 (53000), 525
(55000).
Computational methods
The Gaussian 09[31] software package was used to carry out DFT
and TDDFT calculations with the B3LYP functional and 6-31G(d)
basis set. Structural optimization was performed on model struc-
tures.
Sample preparation for solid-state fluorescence measure-
ments
Synthesis of 5: Benzo[c,d]indole-2(1H)-one (lactam-1, 170 mg,
1.0 mmol) and 2-aminopyridine (amine-2, 94 mg, 1.0 mmol) were
dissolved in toluene (5.3 mL), and then TEA (2 mL) and TiCl4
(0.2 mL) were added to the solution under reflux. After stirring for
15 min, BF3·OEt2 (2.5 mL) was added, and the resulting mixture was
further heated to reflux for 2 h. The reaction mixture was filtered,
and the filtrate was added to water. The organic phase was extract-
ed with chloroform and dried over Na2SO4. Finally the product was
purified by silica gel column chromatography with chloroform as
eluent and recrystallized from chloroform and hexane to afford 5
as a yellow powder in 5.2% yield (15 mg, 0.051 mmol). HR-MALDI-
FT-ICR-MS: m/z 294.1009 (calcd for C16H11BF2N3: 294.1009 [M++H]);
1H NMR (CD2Cl2, 500 MHz, 298 K): d=8.43 (m, 1H), 8.26 (d, J=
7.0 Hz, 1H), 8.14 (d, J=8.0 Hz, 1H), 8.00 (dd, J1 =8.0, J2 =8.0 Hz,
1H), 7.81 (dd, J1 =7.5, J2 =7.0 Hz, 1H), 7.70 (d, J=8.0 Hz, 1H), 7.61
(dd, J1 =8.0, J2 =7.5 Hz, 1H), 7.55 (d, J=8.0 Hz, 1H), 7.48 (d, J=
7.0 Hz, 1H), 7.28 ppm (dd, J1 =7.5, J2 =7.0 Hz, 1H); UV/Vis (CHCl3):
lmax [nm] (e [molÀ1 dm3 cmÀ1])=468 (16000), 441 (24000).
PMMA films for fluorescence measurements were prepared from
a chloroform solution of PMMA (100 mgmLÀ1) containing 0.2 wt%
sample by using a drop-casting method. Amorphous film samples
for fluorescence measurements were prepared by drop casting.
Synthesis of benzo[c,d]indole-containing aza-BODIPYs
Synthesis of 1: Benzo[c,d]indole-2-amine hydroiodide (amine-1,
100 mg, 0.34 mmol) and benzo[c,d]indole-2(1H)-one (lactam-1,
60 mg, 0.34 mmol) were dissolved in toluene (2 mL), and then TEA
(1 mL) and TiCl4 (0.05 mL) were added to the solution under reflux.
After stirring for 15 min, BF3·OEt2 (0.75 mL) was added, and the re-
sulting mixture was further heated to reflux for 2 h. The reaction
mixture was filtered, and the filtrate was added to water. The or-
ganic phase was extracted with chloroform and dried over Na2SO4.
Finally, the product was purified by silica-gel column chromatogra-
phy with chloroform as eluent and recrystallized from chloroform
and methanol to afford 1 as an orange powder in 41% yield
(51 mg, 0.14 mmol). HR-MALDI-FT-ICR-MS: m/z 368.1165 (calcd for
C22H13BF2N3: 368.1165 [M++H]); 1H NMR (CD2Cl2, 500 MHz, 298 K):
d=8.53 (d, J=7.0 Hz, 2H), 8.28 (d, J=7.5 Hz, 2H), 7.90 (m, 4H),
7.84 (d, J=7.0 Hz, 2H), 7.73 ppm (dd, J1 =7.5, J2 =7.0 Hz, 2H); UV/
Vis (CHCl3): lmax [nm] (e [molÀ1 dm3 cmÀ1])=539 (48000), 503
(43000).
Synthesis of 6: Benzo[c,d]indole-2(1H)-one (lactam-1, 0.34 g,
2.0 mmol) and 2-aminobenzooxazole (amine-3, 0.27 g, 2.0 mmol)
were dissolved in toluene (10 mL), and then TEA (5 mL) and TiCl4
(0.3 mL) were added to the solution under reflux. After stirring for
15 min, BF3·OEt2 (4.4 mL) was added, and the resulting mixture was
further heated to reflux for 2 h. The reaction mixture was filtered,
and the filtrate was added to water. The organic phase was extract-
ed with chloroform and dried over Na2SO4. Finally the product was
purified by silica-gel column chromatography with chloroform as
eluent and recrystallized from chloroform and methanol to afford
6 as a yellow powder in 4.3% yield (29 mg, 0.087 mmol). HR-
MALDI-FT-ICR-MS: m/z 334.0958 (calcd for C18H11BF2N3O: 334.0958
[M++H]); 1H NMR (CDCl3, 500 MHz, 298 K): d=8.41 (d, J=7.0 Hz,
1H), 8.22 (d, J=8.0 Hz, 1H), 7.82 (m, 4H), 7.68 (dd, J1 =7.5, J2 =
7.0 Hz, 1H), 7.58 (d, J=8.0 Hz, 1H), 7.49 ppm (m, 2H); UV/Vis
(CHCl3): lmax [nm] (e [molÀ1 dm3 cmÀ1])=468 (8800), 436 (19000).
Synthesis of 3: Benzo[c,d]indole-2-amine hydroiodide (amine-1,
0.51 g, 1.7 mmol) and benzo[c,d]indole-2(1H)-one (lactam-1, 0.30 g,
1.8 mmol) were dissolved in toluene (9 mL), and then TEA (5 mL)
and TiCl4 (0.25 mL) were added to the solution under reflux. After
stirring for 30 min, triphenylborane (0.41 g, 1.7 mmol) was added,
and the resulting mixture was further heated to reflux for 1.5 h.
The reaction mixture was filtered, and the filtrate was added to
water. The organic phase was extracted with chloroform and dried
over Na2SO4. Finally the product was purified by silica gel column
chromatography with chloroform as eluent and recrystallized from
chloroform and methanol to afford 3 as an orange powder in 5.1%
yield (42 mg, 0.086 mmol). HR-MALDI-FT-ICR-MS: m/z 484.1980
Synthesis of 7a: Benzo[c,d]indole-2(1H)-one (lactam-1, 85 mg,
0.50 mmol) and 2-aminobenzothiazole (amine-4a, 75 mg,
0.50 mmol) were dissolved in toluene (2 mL), and then TEA
(1.4 mL) and TiCl4 (0.08 mL) were added to the solution under
reflux. After stirring for 15 min, BF3·OEt2 (1.2 mL) was added, and
the resulting mixture was further heated to reflux for 2 h. The reac-
tion mixture was filtered, and the filtrate was added to water. The
organic phase was extracted with chloroform and dried over
Na2SO4. Finally the product was purified by silica-gel column chro-
matography with chloroform as eluent and recrystallized from
chloroform and methanol to afford 7a as a yellow powder in 16%
yield (28 mg, 0.081 mmol). HR-MALDI-FT-ICR-MS: m/z 350.0729
(calcd for C18H11BF2N3S: 350.0729 [M++H]); 1H NMR (CDCl3,
500 MHz, 298 K): d=8.35 (d, J=7.0 Hz, 1H), 8.19 (d, J=8.0 Hz, 1H),
8.17 (d, J=8.0 Hz, 1H), 7.78 (m, 4H), 7.67 (dd, J1 =8.0, J2 =7.5 Hz,
1H), 7.59 (dd, J1 =8.0, J2 =7.0 Hz, 1H), 7.44 ppm (dd, J1 =8.0, J2 =
7.5 Hz, 1H); UV/Vis (CHCl3): lmax [nm] (e [molÀ1 dm3 cmÀ1])=480
(16000), 450 (25000).
(calcd for C34H23BN3: 484.1980 [M++H]); H NMR (CDCl3, 500 MHz,
1
298 K): d=8.49 (d, J=7.0 Hz, 2H), 8.13 (d, J=8.0 Hz, 2H), 7.83 (dd,
J1 =8.0, J2 =7.0 Hz 2H), 7.63 (m, 6H), 7.32 (m, 4H), 7.21 (m, 4H),
6.85
(d,
J=7.5 Hz,
2H);
UV/Vis
(CHCl3):
lmax [nm]
(e [molÀ1 dm3 cmÀ1])=602 (20000), 561 (23000).
Synthesis of 4: Benzo[c,d]indole-2-amine (amine-1, 0.20 g,
1.2 mmol) and benzo[c,d]indole-2(1H)-one (lactam-1, 0.12 g,
0.68 mmol) were dissolved in toluene (4 mL), and then TEA (2 mL)
and TiCl4 (0.1 mL) were added to the solution under reflux. After
stirring for 2.5 h, the reaction mixture was filtered, and the filtrate
was added to water. The organic phase was extracted with chloro-
form and dried over Na2SO4. After removal of solvent, the residue
was dissolved in CHCl3/MeOH (50 mL, 2/1). Zn(OAc)2 (1.3 g,
6.8 mmol) and NaOAc (56 mg, 6.8 mmol) were then added, and
the resulting mixture was heated to reflux overnight. The reaction
mixture was washed with water, and the organic layer was extract-
ed with chloroform. The extract was purified by silica-gel column
chromatography with CHCl3/MeOH as eluent and GPC-HPLC. Finally
Synthesis of 7b: Benzo[c,d]indole-2(1H)-one (lactam-1, 61 mg,
0.36 mmol) and 2-amino-6-octyloxybenzothiazole (amine-4b,
100 mg, 0.36 mmol) were dissolved in toluene (1.3 mL), and then
Chem. Eur. J. 2015, 21, 12996 – 13003
13001
ꢀ 2015 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim